kronosbio.comHealthcareFounded: 2017Funding to Date: $123MM
Kronos Bio is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription.
